|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07D 207/08 | (2006.01) |
| C07D 211/22 | (2006.01) | ||
| C07D 265/30 | (2006.01) | ||
| C07D 279/12 | (2006.01) | ||
| C07D 401/06 | (2006.01) | ||
| C07D 401/10 | (2006.01) | ||
| C07D 403/06 | (2006.01) | ||
| C07D 413/06 | (2006.01) | ||
| C07D 417/06 | (2006.01) | ||
| A61P 7/06 | (2006.01) | ||
| A61K 31/40 | (2006.01) | ||
| A61K 31/4427 | (2006.01) | ||
| A61K 31/445 | (2006.01) | ||
| A61K 31/4523 | (2006.01) | ||
| A61K 31/497 | (2006.01) | ||
| A61K 31/5375 | (2006.01) | ||
| A61K 31/5377 | (2006.01) | ||
| A61K 31/54 | (2006.01) | ||
| A61K 31/541 | (2006.01) |
| (11) | Patento numeris | 3880654 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 19818401.2 |
| Europos patento paraiškos padavimo data | 2019-11-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-09-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-12-29 |
| (46) | Apibrėžties vertimo paskelbimo data | 2022-02-25 |
| (86) | Numeris | PCT/US2019/062054 |
| Data | 2019-11-18 |
| (87) | Numeris | WO 2020/106642 |
| Data | 2020-05-28 |
| (30) | Numeris | Data | Šalis |
| 201862769196 P | 2018-11-19 | US | |
| 201962821314 P | 2019-03-20 | US | |
| 201962848773 P | 2019-05-16 | US | |
| 201962883313 P | 2019-08-06 | US |
| (72) |
LI, Zhe , US
|
| (73) |
Global Blood Therapeutics, Inc. ,
181 Oyster Point Blvd., South San Francisco, CA 94080,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | 2-Formil-3-hidroksifeniloksimetilo junginiai, galintys moduliuoti hemoglobiną |
| 2-FORMYL-3-HYDROXYPHENYLOXYMETHYL COMPOUNDS CAPABLE OF MODULATING HEMOGLOBIN |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2025-10-14 | 7 | 162.00 EUR |
| 2026-11-18 |